fcrh5 & gprc5d bispecific antibodies: antigen targets beyond bcma for multiple myeloma
Published 1 year ago • 147 plays • Length 0:41Download video MP4
Download video MP3
Similar videos
-
0:29
embl scientists exploring synthetic antibodies to stop coronavirus
-
0:20
covid-19 vs antibody (2020) drew berry wehi.tv
-
0:20
dr jacek mokrosinski discusses how he uses promega’s nanobit® ppi assay in his gpcr research
-
2:02
piv5rights flowrighteous case study - maximum hemodilution subject #5
-
0:59
mitigating cardiological toxicities associated with btki in b-cell malignancies
-
1:54
fbln5 and myc: a lethal partnership in cancer
-
59:27
enhanced protein-protein interactions in living cells using the nanobret ass
-
21:04
cci case reports roundtable episode 2
-
48:02
antibody fc engineering: designing antibodies for cancer, covid-19, and beyond
-
1:18
when science reaches the market - liesbet lagae’s insights
-
0:32
dr jacek mokrosinski discusses how he uses promega’s nanobit® ppi assay in his gpcr research
-
2:05
the association between serum/csf biomarkers and oct measures in cis patients
-
2:32
e-ece 2020: covid-19 symposium
-
3:56
pfizer - 2018 heroes of chemistry
-
7:34
2011 ki symposium: m. celeste simon (part 2 of 3)
-
2:11
covid-19 severity & c5a complement levels | prof eric vivier, aix marseille university/innate pharma
-
3:05
investigating evobrutinib and other btk inhibitors for the treatment of ms
-
20:47
cvi heartbites: covid-19 myocarditis
-
1:10:05
antibodies, genome stability, and cancer
-
1:04
metabolism and response to anti-cgrp treatments in migraine
-
4:32
module 5: biosimilars—advances in research and development
-
2:42
discrete molecular imaging